Viatris Named to USA Today’s Inaugural List of America’s Climate Leaders 2023 - Seite 2

Being named to USA Today's list of America's Climate Leaders 2023 follows previous accolades for Viatris, including on Forbes' list of World's Best Employers 2022, Fortune's Change the World list, Newsweek's America's Most Responsible Companies 2022 list, a Great Place to Work® certification in India, Capital Magazine's Best Employers in France list, and HR Asia's Best Companies to Work for in Asia (Taiwan), among others.

Methodology
Statista compiled a list of several thousand American companies and invited them via email to submit their emissions and revenue data via a website created by Statista and USA Today. The application phase ran from November 28, 2022, to January 15, 2023. In addition, Statista scrutinized publicly available data on approximately 2,000 American companies. The main sources of data are financial and non-financial reports as well as CDP's database. Following the research phase, a second survey was sent to all relevant companies to give them the opportunity to validate their data. To ensure that the data is comparable, only emissions reported following the emissions categories of the Greenhouse Gas Protocol (Scopes 1, 2 and 3) were considered. As there is a high degree of freedom for reporting Scope 3 emissions, these were not considered when calculating the reduction in emissions intensity. If location-based and market-based values have been reported for Scope 2 emissions in both years, then the market-based calculation was used in the analysis (as it reflects the choices a company has made regarding its electricity suppliers). Otherwise, the location-based values were used for both years.

About Viatris
Viatris Inc. (NASDAQ:VTRS) is a global healthcare company empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway®. Formed in November 2020, Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical, and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris' portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized brands, complex generic and branded medicines and a variety of over-the-counter consumer products. With more than 38,000 colleagues globally, Viatris is headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on Twitter at @ViatrisInc, LinkedIn, Instagram and YouTube.